Related Experiment Video
Updated: Jan 17, 2026

10:10
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
1.8K
Exploring Glaucoma: From Pathogenesis to Emerging Diagnostic and Management Strategies
1Department of Ophthalmology, UCLA Jules Stein Eye Institute, Los Angeles, California 90095, USA.
Journal of Ophthalmology
|September 18, 2025
Summary
Glaucoma, a leading cause of irreversible blindness, involves optic nerve damage and vision loss, often linked to high eye pressure. This review synthesizes current glaucoma research, covering classification, causes, diagnosis, and treatment for healthcare professionals.
Area of Science:
- Ophthalmology
- Neuroscience
- Genetics
Background:
- Glaucoma is a primary cause of irreversible blindness worldwide.
- It is characterized by progressive optic neuropathies, retinal ganglion cell loss, and visual field deterioration.
- Elevated intraocular pressure is a significant risk factor, but management remains complex due to varied pathophysiology and lifelong treatment needs.
Purpose of the Study:
- To provide a comprehensive review of the latest advancements in glaucoma research.
- To synthesize current knowledge on glaucoma classification, pathophysiology, risk factors, diagnostic tools, and management strategies.
- To serve as a valuable resource for ophthalmologists, researchers, and healthcare providers.
Main Methods:
- Literature review and synthesis of recent scientific publications.
- Analysis of data from epidemiological studies, clinical trials, and basic science research.
- Multidisciplinary approach integrating findings from ophthalmology, genetics, and neuroscience.
Main Results:
- The review details the complex and heterogeneous nature of glaucoma.
- It highlights recent progress in understanding genetic and molecular mechanisms underlying the disease.
- Current diagnostic tools and evolving management options, including pharmacological, surgical, and emerging therapeutic approaches, are discussed.
Conclusions:
- Glaucoma management requires a comprehensive, multidisciplinary approach due to its complexity.
- Continued research is essential to unravel the intricate pathophysiology and develop more effective treatments.
- This review consolidates current knowledge, identifying key areas for future investigation in the fight against glaucoma-induced blindness.
Related Concept Videos
Glaucoma: Overview
1.3K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.3K
Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Photoreceptors and Visual Pathways
8.8K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.8K

